CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Combination Prevention +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01965470
NCT01965470Phase 4Completed
CompareCT.gov

Botswana Combination Prevention Project: -Evaluation Protocol (Protocol #1): Research Design and Impact Evaluation -Closed Clinical Cohort Protocol (Protocol #3) Implementation, Monitoring and Evaluation of Combination HIV Prevention Interventions in Rural and Peri-Urban Communities in Botswana

Centers for Disease Control and Prevention·interventional·Posted Oct 18, 2013·Updated Nov 14, 2022

In Brief

A Phase 4 clinical trial evaluating Combination Prevention and Enhanced Care for HIV. Completed, across 1 site.

Detailed Summary

The BCPP study is designed to test the hypothesis that implementing an enhanced combination prevention package which includes provision of ART to all participants, regardless of CD4 count or HIV disease severity, will impact the HIV/AIDS epidemic by significantly reducing population-level, cumulative HIV incidence in a defined geographic area over a period of 3 years and will be cost-effective.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV
CountriesBotswana
CollaboratorsBotswana Harvard AIDS Institute Partnership, Botswana Ministry of Health, Harvard School of Public Health (HSPH), Tebelopele Voluntary Counseling and Testing Center

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 18, 2013
Enrollment StartOct 30, 2013
Primary CompletionJul 26, 2018
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 12.7 years ago

Interventions

Combination Preventionother

Enhanced Careother